2Dorfman HD, Czerniak B, Bone caucers. Cancer, 1995,75(1):203-210.
3Siebenlist U, Franzoso G, Brozon K. Structure, regulation and functions of NF-kappa B Ann Rev Cell Biol, 1994,10:455.
4Price CH. Osteogenic sarcoma: An analysis, of survival and its relationship to histological grading and structure. J Bone Joint, Surg,1961,43(B):300-306.
5Dahlin DC, Coventry MB, Osteogenic sarcoma: A study of 600 cases, J Bone Joint Surg, 1967,49(A):101-105.
6Schajowicz F, Sissons HA, Sobin H The World Health Organization's histologic classification of bone tumor. A commentary on the second edition Cancer, 1995,75:l208-1218.
7Higgins KA, Derez JR, Coleman TA, et al. Antisense inhibition of the p65 suhunit of NF-B blocks tumorigenicity and causes tumor regression Proc Natl Acad Sci USA, 1993,90:9901-9905.
8Yang J, Xu Y, Zhu C, et al. Regulation of adhesion molecule expression in Kaposi's sarcoma cells. J Immunol, 1994, 152(1) :361-378.
9Wang CY, Mayo MW, Jr Baldwin AS. TNF and cancer therapy-induced apoptosis : potentiation by inhibition of NF-B. Science, 1996,274:784-786.
10Ueda Y,Nakanishi I.Immunohistochemical and biochemical studies the collagenous proteins of human osteosarcoma.Virchows Archio B Cell Pathol,1989,58(1):79-88.
